Usefulness of urinary CTX-II and NTX-I in evaluating radiological knee osteoarthritis:the Matsudai knee osteoarthritis survey

Journal of Orthopaedic Science

Volumn 19, Issue 3, 2014, Pages 429-436

  Tanishi, Nobuchika ^a,b   Yamagiwa, Hiroshi ^a   Hayami, Tadashi ^c   Mera, Hisashi ^a   Koga, Yoshio ^d   Omori, Go ^e   Endo, Naoto ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Japan Organization of Occupational Health and Safety   (Japan)

^c Saiseikai Niigata Daini Hospital   (Japan)

^d Department of Orthopedic Surgery Niigata Medical Center   (Japan)

^e NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; BISPHOSPHONIC ACID DERIVATIVE; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; COLLAGEN TYPE 2; CREATININE; UNCLASSIFIED DRUG; URINARY CROSSLINKED C TELOPEPTIDE OF TYPE II COLLAGEN; URINARY CROSSLINKED N TELOPEPTIDE OF TYPE I COLLAGEN; BIOLOGICAL MARKER; BONE DENSITY CONSERVATION AGENT; C-TERMINAL CROSS-LINKING TELOPEPTIDE OF TYPE II COLLAGEN, HUMAN; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; PEPTIDE; PEPTIDE FRAGMENT;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL EVALUATION; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEALTH SURVEY; HUMAN; JAPAN; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; POSTMENOPAUSE; SENSITIVITY AND SPECIFICITY; TOTAL KNEE REPLACEMENT; URINE LEVEL; AGE; MIDDLE AGED; RADIOGRAPHY; SEX DIFFERENCE; URINE;

ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; BONE DENSITY CONSERVATION AGENTS; COLLAGEN TYPE I; COLLAGEN TYPE II; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PEPTIDE FRAGMENTS; PEPTIDES; SENSITIVITY AND SPECIFICITY; SEX FACTORS;

EID: 84902813290     PISSN: 09492658     EISSN: 14362023     Source Type: Journal    
DOI: 10.1007/s00776-014-0535-1     Document Type: Article

References (16)

1. Rousseau JCh, Garnero P. Biological markers in osteoarthritis. Bone. 2012;51:265-77.
2. Garnero P, Landewé R, Boers M, Verhoeven A, Van Der Linden S, Christgau S, Van Der Heijde D, Boonen A, Geusens P. Association of baseline levels of markers of bone and cartilage degradation with long-tern progression of joint damage in patients with early rheumatoid arthritis. The COBRA study. Arthritis Rheum. 2002;46:2847-56. (Pubitemid 35315875)
3. Landewé R, Geusens P, Boers M, van der Heijde D, Lems W, Koppele J, van der Linden S, Garnero P. Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis. Arthritis Rheum. 2004;50:1390-9. (Pubitemid 38608060)
4. Garnero P, Conrozier T, Christgau S, Mathieu P, Delmas PD, Vignon E. Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis. Ann Rheum Dis. 2003;62:939-43. (Pubitemid 37159491)
5. Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis. 2001;60:619-26. (Pubitemid 32493990)
6. Jordan KM, Syddall HE, Garnero P, Gineyts E, Dennison EM, Sayer AA, Delmas PD, Cooper C, Arden NK. Urinary CTX-II and glucosyl-galactosyl- pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men. Ann Rheum Dis. 2006;65:871-7.
7. Hayami T, Pickarski M, Wesolowski GA, McLane J, Bone A, Destefano J, Rodan GA, le Duong T. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum. 2004;50:1193-206. (Pubitemid 38480830)
8. Shiozaki H, Koga Y, Omori G, Yamamoto G, Takahashi HE. Epidemiology of osteoarthritis of the knee in a rural Japanese population. Knee. 1999;6:183-8. (Pubitemid 29456874)
9. Shiozaki H, Koga Y, Omori G, Tamaki M. Obesity and osteoarthritis of the knee in women; results of Matsudai Knee Osteoarthritis Survey. Knee. 1999;6:189-92. (Pubitemid 29456875)
10. Tanishi N, Yamagiwa H, Hayami T, Mera H, Koga Y, Omori G, Endo N. Relationship between radiological knee osteoarthritis and biochemical markers of cartilage and bone degradation (urine CTX-II and NTX-I): the Matsudai Knee Osteoarthritis Survey. J Bone Miner Metab. 2009;27:605-12.
11. Mouritzen U, Christgau S, Lehmann HJ, Tankó LB, Christiansen C. Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass index. Ann Rheum Dis. 2003;62:332-6. (Pubitemid 36363439)
12. Lehmann HJ, Mouritzen U, Christgau S, Cloos PA, Christiansen C. Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products. Ann Rheum Dis. 2002;61:530-3. (Pubitemid 34539098)
13. Sone T, Miyake M, Takeda N, Fukunaga M. Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults: age- and sex-related changes and reference limits. Bone. 1995;17:335-9.
14. Bauer DC, Hunter DJ, Abramson SB, Attur M, Corr M, Felson D, Heinegård D, Jordan JM, Kepler TB, Lane NE, Saxne T, Tyree B, Kraus VB, Osteoarthritis Biomarkers Network. Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage. 2006;14:723-7.
15. Sowers MF, Karvonen-Gutierrez CA, Yosef M, Jannausch M, Jiang Y, Garnero P, Jacobson J. Longitudinal changes of serum COMP and urinary CTX-II predict X-ray defined knee osteoarthritis severity and stiffness in women. Osteoarthritis Cartilage. 2009;17:1609-14.
16. Kong SY, Stabler TV, Criscione LG, Elliott AL, Jordan JM, Kraus VB. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis. Arthritis Rheum. 2006;54:2496-504. (Pubitemid 44205010)